MORONI, FLAVIO
MORONI, FLAVIO
Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA)
(+)MCPG induces PKC-epsilon translocation in cortical synaptosomes through a PLD-coupled mGluR
2000 Pastorino L.; Colciaghi F.; Gardoni F.; Albani-Torregrossa S.; Pellegrini-Giampietro D.E.; Moroni F.; De Graan P.N.E.; Cattabeni F.; Di Luca M.
(2R, 1’S, 2’R, 3’S)-2-(2’-Carboxy-3’-phenylcyclopropyl)glycine (PCCG-13), the first potent and selective competitive antagonist of PLD-coupled metabotropic receptors. Asymmetric synthesis and preliminary biological reports.
1999 Pellicciari R.; Marinozzi M.; Costantino G.; Natalini B.; Moroni F.; Pellegrini-Giampietro D.
1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia
1999 Pellegrini-Giampietro D.E.; Cozzi A.; Leonardi P.; Peruginelli F.; Meli E.; Pellicciari R.; Moroni F.
1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors.
1995 R. Pellicciari;R. Luneia;G. Costantino;M. Marinozzi;B. Natalini;P. Jakobsen;A. Kanstrup;G. Lombardi;F. Moroni;C. Thomsen
1-Methyl-4-Phenylpyridinium (Mpp+) Modulates Hyperpolarization-Activated Current (Ih) In Substantia Nigra Pars Compacta Dopaminergic Neurons
2012 A. Masi; R. Narducci; F. Moroni; G. Mannaioni
1-methyl-4-phenylpyridinium (MPP+) modulates hyperpolarization-activated current (Ih) in substantia nigra pars compacta dopaminergic neurons.
2011 A. Masi; R. Narducci; F. Moroni; G. Mannaioni
18β-glycyrrhetic acid inhibits immune activation triggered by HMGB1, a pro-inflammatory protein found in the tear fluid during conjunctivitis and blepharitis
2011 L. Cavone; M. Muzzi; R.; Mencucci; M. Pedrazzi; B. Sparatore; F. Moroni; A. Chiarugi
5-HYDROXYINDOLE CAUSES CONVULSIONS AND INCREASES TRANSMITTER RELEASE IN THE CA1 REGION OF RAT HIPPOCAMPUS
2003 G. MANNAIONI; R. CARPENEDO; F. MORONI
8-phenyltheophylline potentiates the evoked electrical activity in hippocampal slices.
1984 R. CORRADETTI; F. MORONI; MB. PASSANI; G. PEPEU
[The problem of the addictive capacity of zipeprol. Results of an experimental and clinical investigation].
1986 F. Moroni;P. F. Mannaioni
A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation.
2007 ALDINUCCI A; GERLINI G; FOSSATI S; CIPRIANI G; BALLERINI C; BIAGIOLI T; PIMPINELLI N; BORGOGNONI L; MASSACESI L; MORONI F; CHIARUGI A.
A mass-fragmentographic approach to release studies of endogenous GABA, glutamic acid and glutamine "in vitro".
1980 F. Moroni;S. Tanganelli;C. Bianchi;G. Moneti;L. Beani
A new endogenous anxiolytic agent: L-pyroglutamic acid.
1988 Beni M.; Pellegrini-Giampietro D.E.; Moroni F.
A study of the dose dependency of a glycine receptor antagonist in focal ischemia.
1993 J. Chen;S. Graham;F. Moroni;R. Simon
A trend in the therapy of Amanita phalloides poisoning.
1976 F. Moroni;R. Fantozzi;E. Masini;P. F. Mannaioni
Acetylcholine and amino acid neurotransmitters in epidural cups of freely moving rats: effect of acute and chronic treatment with antischizophrenic drugs.
1980 Moroni F; Casamenti F; Caliari S; Pisani G; Moneti G; Pepeu G.
Action of antischizophrenic drugs on the metabolism of gamma-aminobutyric acid and acetylcholine in globus pallidus, striatum and n. accumbens.
1978 E. Costa;D. L. Cheney;C. C. Mao;F. Moroni
Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo.
2002 Meli E.; Picca R.; Attucci S.; Cozzi A.; Peruginelli F.; Moroni F.; Pellegrini-Giampietro D.E.
Acute changes of blood ammonia may predict short-term adverse effects of valproic acid.
1984 G. Zaccara;R. Campostrini;M. Paganini;F. Moroni;T. Valenza;G. Targioni;G. Arnetoli;R. Zappoli;A. Baruzzi
Acute cyanide intoxication treated with a combination of hydroxycobalamin, sodium nitrite, and sodium thiosulfate.
2002 Mannaioni G; Vannacci A; Marzocca C; Zorn AM; Peruzzi S; Moroni F